Search all medical codes

Hormone resistant malignancy status

ICD10CM code

Medical Policies and Guidelines for Hormone resistant malignancy status

Related policies from health plans

Jevtana (cabazitaxel)
Provenge (sipuleucel-T)
Radioimmunotherapy and Somatostatin Receptor Targeted Radiotherapy
Xofigo (Radium Ra 223 Dichloride)
Transthoracic Echocardiography in Children - (0523)
Concert Genetic Oncology: Circulating Tumor DNA Tumor Cells Liquid Biopsy (PDF)

Similar Codes


ICD10CM codes

Z19.2 - Hormone resistant malignancy status
Z19.1 - Hormone sensitive malignancy status
Z19 - Hormone sensitivity malignancy status
Z17 - Estrogen receptor status
Z17.1 - Estrogen receptor negative status [ER-]
Z85 - Personal history of malignant neoplasm
Z85.9 - Personal history of malignant neoplasm, unspecified
Z80.9 - Family history of malignant neoplasm, unspecified
Z15.0 - Genetic susceptibility to malignant neoplasm
Z85.85 - Personal history of malignant neoplasm of endocrine glands

HCPCS codes

G9842 - Patient has metastatic disease at diagnosis
G9097 - Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
G8927 - Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer
G8875 - Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
J9999 - Not otherwise classified, antineoplastic drugs
G9396 - Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve m
G9918 - Functional status not performed, reason not otherwise specified
J7599 - Immunosuppressive drug, not otherwise classified
G9365 - One high-risk medication ordered
J9356 - Injection, trastuzumab, 10 mg and Hyaluronidase-oysk

CPT4 codes

3316F - Estrogen receptor (ER) and progesterone receptor (PR) negative breast cancer (ONC)
3315F - Estrogen receptor (ER) or progesterone receptor (PR) positive breast cancer (ONC)
3374F - AJCC Breast Cancer Stage I: T1c (tumor size > 1 cm to 2 cm) documented (ONC)
81500 - Oncology (ovarian), biochemical assays of two proteins (CA-125 and HE4), utilizing serum, with menop
1150F - Documentation that a patient has a substantial risk of death within 1 year (Pall Cr)
39220 - Resection of mediastinal tumor
3388F - AJCC colon cancer, Stage III documented (ONC)
3344F - Mammogram assessment category of suspicious, documented (RAD)
88239 - Tissue culture for neoplastic disorders; solid tumor
3776F - Adenoma(s) or other neoplasm not detected during screening colonoscopy (SCADR)